Castleark Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Castleark Management’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-162,410	Closed	-$4.63M	–	414
2018 Q4	$4.63M	Sell	162,410 -9,620	-6%	-$306K	0.2%	151
2018 Q3	$6.73M	Buy	+172,030	New	+$6.36M	0.19%	167
2017 Q1	–	Sell	-358,785	Closed	-$8.69M	–	419
2016 Q4	$8.69M	Buy	358,785 +3,990	+1%	+$97.9K	0.28%	123
2016 Q3	$8.42M	Buy	+354,795	New	+$7.77M	0.25%	123
2015 Q2	–	Sell	-273,575	Closed	-$10.7M	–	399
2015 Q1	$10.7M	Buy	+273,575	New	+$9.42M	0.26%	120
2014 Q4	–	Sell	-259,270	Closed	-$8.24M	–	409
2014 Q3	$8.24M	Buy	259,270 +51,266	+25%	+$1.46M	0.23%	100
2014 Q2	$6.48M	Sell	208,004 -51,266	-20%	-$1.48M	0.18%	135
2014 Q1	$8.24M	Buy	259,270 +71,320	+38%	+$2.36M	0.23%	100
2013 Q4	$6.45M	Buy	+187,950	New	+$5.47M	0.19%	105
2013 Q3	–	Sell	-158,125	Closed	-$3.35M	–	414
2013 Q2	$3.35M	Buy	+158,125	New	+$3.07M	0.11%	146

Other funds holding CSII

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Castleark Management's CSII Position: Q1 2019 in Review

Castleark Management sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2019, closing a stake of 162,410 shares — an estimated $4.63M sold.

Castleark Management first reported a position in CSII in Q2 2013 and held it in 10 quarters. The position peaked at $10.7M in Q1 2015. 186 funds tracked by Wall St. Rank hold CSII as of Q1 2019.

Castleark Management reported no remaining Cardiovascular Systems, Inc. position as of Q1 2019 after selling out during the quarter.
Castleark Management sold 162,410 Cardiovascular Systems, Inc. shares in Q1 2019, an estimated $4.63M.
Castleark Management first reported a position in Cardiovascular Systems, Inc. in Q2 2013 and held it in 10 quarters.
Castleark Management's Cardiovascular Systems, Inc. position peaked at $10.7M in Q1 2015.
186 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2019.

Based on Castleark Management's 13F filing for Q1 2019, filed 14 May 2019.